In this issue:
- Comparison of guidelines for evaluating suspected PE in pregnancy
- No VTE recurrence after hospitalisation for COVID-19 with VTE
- Psoriasis increases incident VTE
- VTE risk increased in prostate cancer
- Prognostic assessment and management pathway for acute PE patients
- Heart rate and mortality in acute symptomatic PE
- Diagnostic accuracy of point-of-care ultrasound in suspected PE
- Role of ANGPT2 in venous thrombus resolution in CTEPH
- Role of von Willebrand factor in CTEPH
- HFPEF in patients with unexplained dyspnoea
- Mortality trends in PAH in Canada
- Temporal trends in PAH in Europe
- Selexipag for CTEPH
- BMI and PAH treatment response
- Validation of four-stratum risk assessment for PH
Please login below to download this issue (PDF)